News Archive

January 3, 2022

An earns National Academy of Inventors fellowship

GSBS faculty member Zhiqiang An, PhD

GSBS faculty member Zhiqiang An, PhD, has been named a fellow of the National Academy of Inventors (NAI), the organization announced Dec. 7. The NAI Fellows Program highlights academic inventors who have demonstrated a spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society. Election to NAI Fellow is the highest professional distinction accorded solely to academic inventors.


December 10, 2021

Tumors May Shed Protein to Create Barriers that Block Immune Cells

NCI Staff

Tumors May Shed Protein to Create Barriers that Block Immune Cells

Scientists have identified a protein that may help prevent immune cells from entering breast tumors and killing the cancer cells. The research, which was conducted primarily in mice, could lead to potential strategies for overcoming barriers that keep certain immune cells from attacking tumors, according to the investigators.


June 15, 2021

Could a Nasal Spray of Designer Antibodies Help to Beat COVID-19?

Dr. Francis Collins

Could a Nasal Spray of Designer Antibodies Help to Beat COVID-19?

There are now several monoclonal antibodies, identical copies of a therapeutic antibody produced in large numbers, that are authorized for the treatment of COVID-19. But in the ongoing effort to beat this terrible pandemic, there’s plenty of room for continued improvements in treating infections with SARS-CoV-2, the virus that causes COVID-19.


April 1, 2021

Study finds why some cancer drugs may be ineffective

Researchers with UTHealth have found a possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials. (Photo by Getty Images)

A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and McGovern Medical School.


January 21, 2021

New antibody therapies found to potentially fight COVID-19

Researchers have discovered a potential new antibody therapy for COVID-19. (Photo by UTHealth)

Researchers at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas Medical Branch at Galveston (UTMB Health) have discovered a potential new antibody therapy for COVID-19. The study was published in Nature Communications.


December 11, 2020

The first virtual Symposium of the CPRIT Therapeutic Antibody Core

The annual symposium of the CPRIT Therapeutic Antibody Core took place on Friday, December 11, 2020, from 1:00 pm Central Time. For the safety of participants during the COVID-19 pandemic, the symposium was held online via WebEx. Speakers highlighted the core’s capacities and provided examples of successful core collaborations.